ResearcherUniversitätsklinikum TübingenNo recent work listed

Vindhya Palagani

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5060082107. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2014: 1 paper

Papers 1

Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression. Co-author DOI 10.1093/carcin/bgt394 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ruben R. Plentz · 1 shared paper, 2014 · strength 0.04
- Paper Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression. DOI 10.1093/carcin/bgt394 ↗
Nathalia A. Giese · 1 shared paper, 2014 · strength 0.04
- Paper Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression. DOI 10.1093/carcin/bgt394 ↗
Przemyslaw M. Bozko · 1 shared paper, 2014 · strength 0.04
- Paper Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression. DOI 10.1093/carcin/bgt394 ↗
Bence Sipos · 1 shared paper, 2014 · strength 0.04
- Paper Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression. DOI 10.1093/carcin/bgt394 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.